Oscillatory beta dynamics inform biomarker-driven treatment optimization for Parkinson’s disease
Journal of Neurophysiology · 01.06.2023 · 129 (6) · 1492-1504
DOI: 10.1152/jn.00055.2023 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neurophysiology, erschienen am 01.06.2023. Verfasst von Erin M Radcliffe und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States. Hauptthemen laut MEDLINE: Parkinson Disease, Deep Brain Stimulation, Subthalamic Nucleus. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 152 Literaturangaben.
Abstract (Originalsprache)
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by loss of dopaminergic neurons and dysregulation of the basal ganglia. Cardinal motor symptoms include bradykinesia, rigidity, and tremor. Deep brain stimulation (DBS) of select subcortical nuclei is standard of care for medication-refractory PD. Conventional open-loop DBS delivers continuous stimulation with fixed parameters that do not account for a patient’s dynamic activity state or medication cycle. In comparison, closed-loop DBS, or adaptive DBS (aDBS), adjusts stimulation based on biomarker feedback that correlates with clinical state. Recent work has identified several neurophysiological biomarkers in local field potential recordings from PD patients, the most promising of which are 1) elevated beta (∼13–30 Hz) power in the subthalamic nucleus (STN), 2) increased beta synchrony throughout basal ganglia-thalamocortical circuits, notably observed as coupling between the STN beta phase and cortical broadband gamma (∼50–200 Hz) amplitude, and 3) prolonged beta bursts in the STN and cortex. In this review, we highlight relevant frequency and time domain features of STN beta measured in PD patients and summarize how spectral beta power, oscillatory beta synchrony, phase-amplitude coupling, and temporal beta bursting inform PD pathology, neurosurgical targeting, and DBS therapy. We then review how STN beta dynamics inform predictive, biomarker-driven aDBS approaches for optimizing PD treatment. We therefore provide clinically useful and actionable insight that can be applied toward aDBS implementation for PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States.
- Department of Bioengineering, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States.
- Department of Neurology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States.
- Department of Computer Science and Engineering, University of Colorado Denver, Denver, Colorado, United States.
ORCID-Profile: Erin M Radcliffe, Alexander J Baumgartner, John A Thompson
Zitieren
APA
Radcliffe, E. M., Baumgartner, A. J., Kern, D. S., Al Borno, M., Ojemann, S., Kramer, D. R., & Thompson, J. A. (2023). Oscillatory beta dynamics inform biomarker-driven treatment optimization for Parkinson’s disease. Journal of Neurophysiology, 129(6), 1492-1504. https://doi.org/10.1152/jn.00055.2023
Vancouver
Radcliffe EM, Baumgartner AJ, Kern DS, Al Borno M, Ojemann S, Kramer DR, et al. Oscillatory beta dynamics inform biomarker-driven treatment optimization for Parkinson’s disease. Journal of Neurophysiology. 2023;129(6):1492-1504. doi:10.1152/jn.00055.2023
BibTeX
@article{Radcliffe2023,
author = {Radcliffe, Erin M and Baumgartner, Alexander J and Kern, Drew S and Al Borno, Mazen and Ojemann, Steven and Kramer, Daniel R and Thompson, John A},
title = {Oscillatory beta dynamics inform biomarker-driven treatment optimization for Parkinson’s disease},
journal = {Journal of Neurophysiology},
year = {2023},
volume = {129},
number = {6},
pages = {1492--1504},
doi = {10.1152/jn.00055.2023}
}
EUVIMED